Biotricity (BTCY) Price & Analysis

Compare

118 Followers

BTCY Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.19 - $0.83

Previous CloseN/A

Volume50.15K

Average Volume (3M)47.67K

Market Cap

$12.83M

Enterprise Value$34.11M

Total Cash (Recent Filing)$391.29K

Total Debt (Recent Filing)$13.29M

Price to Earnings (P/E)―

Beta-0.33

Next Earnings

Nov 12, 2025

EPS Estimate

-0.08

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.03

Shares Outstanding26,567,768

10 Day Avg. Volume55,658

30 Day Avg. Volume47,667

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap2.66

Enterprise Value/Revenue2.36

Enterprise Value/Gross Profit3.01

Enterprise Value/Ebitda-31.00

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

Financial PerformanceBiotricity reported a doubling of free cash flow compared to FY2Q25 on an 11% increase in sales to $3.6M.

Product InnovationProduct innovation remains a catalyst as the next-generation, cellular-enabled Biocore Pro gains traction, and strategic partnerships extend Biotricity’s remote monitoring algorithms into new markets.

Strategic PartnershipsBiotricity's partnerships with top group purchasing organizations and specialist organizations in neurology and pulmonology are gaining traction.

Bears Say

Financial RatingWhile there is stable growth and a bullish outlook, a Neutral rating is maintained as expansion consistency, initiative outcomes, and respective financial impact are monitored.

Market RisksAn investment in Biotricity is subject to the risks inherent in all small-cap companies, including dilution, end-market product acceptance and pricing, and competition against companies with greater resources.

Biotricity News

Biotricity reports Q1 EPS (3c) vs (49c) last year

Reports Q1 revenue $3.9M vs. $3.2M in Q4. Dr. Waqaas Al-Siddiq, Biotricity (BTCY) Founder & CEO, said, “We’re...

10d ago

BTCY

Biotricity Inc. Reports Improved Financial Performance

Biotricity ( ($BTCY) ) has released its Q1 earnings. Here is a breakdown of the information Biotricity presented...

9d ago

BTCY

Biotricity’s Earnings Call: Progress Amid Challenges

Biotricity (($BTCY)) has held its Q4 earnings call. Read on for the main highlights of the call. Biotricity’s...

1M ago

BTCY

Biotricity Inc. Expands Cardiac Monitoring Solutions

Biotricity ( ($BTCY) ) has released its Q4 earnings. Here is a breakdown of the information Biotricity presented...

1M ago

BTCY

Biotricity Inc. Delays Yearly Report Filing

Biotricity ( ($BTCY) ) has released a notification of late filing. Biotricity Inc. has announced a delay in...

2M ago

BTCY

BTCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Biotricity (BTCY) is scheduled to report 4th quarter earnings on 06/27/2025. Regarding Q4 estimates, Wall Street analysts expect...

2M ago

BTCY

Ten option delistings on March 24th

Option delistings effective March 24th include Aligos Therapeutics (ALGS), Allbirds (BIRD), Biotricity Inc (BTCY), DWTX Stock (DWTX), Dixie...

5M ago

GWH

ALGS

Biotricity expands IP portfolio with 14 new patents

Biotricity (BTCY) announced the expansion of its intellectual property portfolio with 14 new patents. This brings the company’s...

5M ago

BTCY

Biotricity reports Q3 EPS (5c) vs. (34c) last year

Reports Q3 revenue $3.6M, up 21.7% year-over-year. Waqaas Al-Siddiq, Biotricity (BTCY) Founder & CEO, said, “In the third...

6M ago

BTCY

Biotricity Reports Revenue Growth Amidst Financial Challenges

Biotricity ( ($BTCY) ) has released its Q3 earnings. Here is a breakdown of the information Biotricity presented...

6M ago

BTCY

Biotricity Notifies Delay in Quarterly Report Filing

Biotricity ( ($BTCY) ) has released a notification of late filing. Biotricity Inc., a company based in Redwood...

6M ago

BTCY

Biotricity Reports Revenue Growth Amidst Ongoing Losses

Biotricity ( ($BTCY) ) has released its Q2 earnings. Here is a breakdown of the information Biotricity presented...

9M ago

BTCY

Biotricity reports Q2 EPS (7c) vs. (44c) last year

Reports Q2 revenue $3.3M vs. $2.89M last year. Waqaas Al-Siddiq, CEO, said, “In the second quarter of fiscal...

9M ago

BTCY

Options Volatility and Implied Earnings Moves Today, November 15, 2024

Today, several major companies are expected to report earnings: Spectrum Brands Holdings (SPB), Alibaba (BABA), Biotricity (BTCY), Sigma...

9M ago

RLX

SPB

BTCY FAQ

What was Biotricity Inc’s price range in the past 12 months?

Biotricity Inc lowest stock price was $0.19 and its highest was $0.83 in the past 12 months.

What is Biotricity Inc’s market cap?

Biotricity Inc’s market cap is $12.83M.

When is Biotricity Inc’s upcoming earnings report date?

Biotricity Inc’s upcoming earnings report date is Nov 12, 2025 which is in 80 days.

How were Biotricity Inc’s earnings last quarter?

Biotricity Inc released its earnings results on Aug 14, 2025. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of N/A by $0.03.

Is Biotricity Inc overvalued?

According to Wall Street analysts Biotricity Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Biotricity Inc pay dividends?

Biotricity Inc does not currently pay dividends.

What is Biotricity Inc’s EPS estimate?

Biotricity Inc’s EPS estimate is -0.08.

How many shares outstanding does Biotricity Inc have?

Biotricity Inc has 26,567,768 shares outstanding.

What happened to Biotricity Inc’s price movement after its last earnings report?

Biotricity Inc reported an EPS of $0.03 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Biotricity Inc?

Currently, no hedge funds are holding shares in BTCY

Company Description

Biotricity Inc

Biotricity Inc. (BTCY) is a medical technology company that specializes in the development and commercialization of remote biometric monitoring solutions. The company focuses on delivering innovative, real-time remote monitoring solutions for chronic conditions and lifestyle improvement. Its core product, Bioflux, is a mobile cardiac telemetry device that provides continuous, real-time monitoring for patients with cardiac conditions, enhancing the capabilities of healthcare providers to diagnose and manage these conditions effectively.

Biotricity (BTCY) Earnings & Revenues

Historic Earnings Reports

BTCY Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Biotricity showed significant advancements and strategic partnerships leading to revenue growth and reduced operating expenses, positioning the company close to profitability. Despite ongoing net losses and long sales cycles, the positive developments, such as international approvals and gross margin improvements, indicate a strong trajectory towards sustainable growth.View all BTCY earnings summaries

BTCY Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"NaN":"―"}},"plotLines":[{"color":"rgba(0,0,0,0)","label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">―</span>\n  </div></div>","useHTML":true}}],"tickPositions":[null,null,null,null,null],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,{"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.4,0.36923076923076925,0.3384615384615385,0.3076923076923077,0.27692307692307694,0.24615384615384617,0.2153846153846154,0.18461538461538463,0.15384615384615385,0.12307692307692308,0.09230769230769231,0.06153846153846154,0.03076923076923077,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,{"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.11,"date":1667260800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.92,"date":1675209600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.82,"date":1688169600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.67,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.96,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.41,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.27,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.29,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.39,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.53,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.38,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.4,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >